Abstract #1383

QSM and R2* capture physical and cognitive impairment in multiple sclerosis

Vanessa Wiggermann^1,2, Shawna Abel³, Irene M Vavasour⁴, Enedino Hernández-Torres³, Christian Kames^1,2, David KB Li^4,5, Roger Tam^4,5, Shannon H Kolind^1,3, Anthony Traboulsee³, and Alexander Rauscher^1,2

¹Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada, ²Pediatrics, University of British Columbia, Vancouver, BC, Canada, ³Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, ⁴Radiology, University of British Columbia, Vancouver, BC, Canada, ⁵MS/MRI Research (Neurology), University of British Columbia, Vancouver, BC, Canada

Abnormalities seen on clinical MRIs in the brain and spinal cord of multiple sclerosis (MS) patients lack specificity to myelin. Thus, efficacy of new treatments that aim to protect or remyelinate cannot be fully captured. Quantitative MR metrics, such as R₂* and quantitative susceptibility mapping (QSM), have demonstrated good sensitivity to myelin and iron-related tissue changes, but the clinical relevance of such changes has not yet been assessed. We showed that R₂* provides good group-wise distinction of MS patients and controls, while QSM values reflected clinically meaningful variations in upper and lower motor function as well as cognitive processing speed.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.